New Medicines Service — Community Pharmacy


The service provides support for people with long-term conditions newly prescribed a medicine to helpimprove medicines adherence; it is initially focused on particular patient groups and conditions. 

Who to Refer

Patients with the following long term conditionsnewly prescribed one of the listed medicines:

Asthma and COPD - Adrenoceptor agonists; Antimuscarinic bronchodilators; Theophylline; Compound bronchodilator preparations; Inhaled corticosteroids; Cromoglicate and related therapy, leukotriene receptor antagonists and phosphodiesterase type-4 inhibitors.

Type 2 Diabetes - Short acting insulins*; Intermediate and long acting insulins*; Antidiabetic drugs.

Antiplatelet/anticoagulant therapy - Oral anticoagulants; Antiplatelet drugs.

Hypertension - Thiazides and related diuretics; Beta-adrenoceptor blocking drugs*; Vasodilator antihypertensive drugs; Centrally acting antihypertensive drugs; Alpha-adrenoceptor blocking drugs*; Drugs affecting the renin-angiotensin system*; Calcium channel blockers*.

* where the community pharmacist can determine that the medicine has been newly prescribed for the specified condition.

Please note: when seeking/receiving advice in regard to patient care and making referrals, NHS Connecting for Health Information Governance standards and policies must be adhered to.

Who not to Refer

Patients who have not beennewly prescribedone of the medicines listed above.


Pharmacy services negotiating committee information on new medicines service

Last updated: 26/04/2012

Update due: 26/04/2013